Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
Kidney diseases are rising globally in importance relative to other chronic diseases and are integral to the Cardiovascular-Kidney-Metabolic Syndrome. Recognizing its public health significance, the US Centers for Disease Control and Prevention’s Kidney Disease Surveillance System (KDSS) was mandated by the US Congress in 2005 toward exclusively for monitoring non-end-stage kidney disease in the US, and iteratively established over the first 5 years, and continuously maintained and enhanced with significant interdisciplinary input from federal and non-federal stakeholders.
Data and trends on major topics, measures (concepts) – e.g., incidence and prevalence, and indicators (specific statistics with respect to individual measures) in different settings/data sources; e.g., health systems, or population level, are derived from multiple, large national-level survey data (National Health and Nutrition Examination Survey), electronic medical record data (Military and Veterans Affairs Health Systems), health care claims (Medicare, Optum-a private health insurance database), national laboratory data (Labcorp, Inc.), and social determinants of health data (e.g., American Community Survey).
Few highlights: The prevalence of chronic kidney disease (CKD) among civilian US adults remains steady between 13%─14%. Prevalence is higher among older, female, non-Hispanic Black adults, and those with diabetes or hypertension. Among US veterans, the incidence of CKD and rates of diagnosis of acute kidney injury (AKI) increased from 2008 to 2022 (Incidence: 62.8 to 71.5/1,000 person-years, AKI: 84.9 to 241.7 cases/1,000 person-years. Awareness of the disease nationwide among persons with CKD was low (<10%), but starting in 2013, has increased to approximately 25%. Persons with CKD self-report more problems with sleep, and those aged 65 and older self-report a higher prevalence of functional limitations. Improvements in quality-of-care measures, including medication prescription (e.g., SGLT-2 inhibitors) and increases in albuminuria testing were observed. Increased self-reported physical activity was observed among persons with CKD. Food insecurity increased among persons with CKD, with the highest prevalence in young, female, non-Hispanic Black, and Hispanic adults. An example of the CKD Awareness indicator using data from NHANES is shown in the Figure. Further details are available at https://www.cdc.gov/kdss/.
Robust disease surveillance is key to raising awareness of kidney disease, its risk factors, care quality, and outcomes. While population-level prevalence of CKD in the US remains stable, awareness is beginning to rise over the last decade along with higher AKI and CKD rates being observed in health systems settings. KDSS is also helping to identify hotspots of kidney disease in the US by geography using geospatial mapping strategies, and can iteratively inform policy and action toward prevention of kidney disease at national and regional levels.
